Related Experiment Video
Updated: May 3, 2026

10:38
Induction of Experimental Autoimmune Hypophysitis in SJL Mice
Published on: December 17, 2010
11.1K
A humanized mouse model of autoimmune insulitis
Ashley A Viehmann Milam1, Stephen E Maher, Joanna A Gibson
1Department of Immunobiology, Yale University School of Medicine, New Haven, CT.
Diabetes
|January 31, 2014
Summary
Researchers developed a new in vivo model for type 1 diabetes using human CD4(+) T cells. This model successfully demonstrated autoimmune destruction of pancreatic beta cells, offering a valuable tool for diabetes research.
Area of Science:
- Immunology
- Endocrinology
- Transplantation Biology
Background:
- Current type 1 diabetes research models, like the NOD mouse, often fail to replicate human disease mechanisms.
- A critical need exists for an in vivo system to study the development and onset of human autoimmune diabetes.
Purpose of the Study:
- To characterize a novel in vivo system for studying human autoimmune diabetes using human CD4(+) T cells and a specialized mouse model.
- To assess the ability of autoantigen-pulsed human CD4(+) T cells to induce pancreatic beta-cell destruction in vivo.
Main Methods:
- Human CD4(+) T cells were pulsed with autoantigen-derived peptides.
- These pulsed cells were injected into NOD-Scid Il2rg(-/-) mice expressing the human HLA-DR4 transgene.
- Islet infiltration, insulitis, insulin staining, and levels of beta-cell-derived DNA in the bloodstream were analyzed.
Main Results:
- Injection of as few as 0.5 × 10(6) antigen-pulsed human CD4(+) T cells led to T cell infiltration of mouse islets.
- Diabetic donor T cells induced significantly greater insulitis and reduced insulin staining compared to healthy donor cells.
- Reduced insulin staining correlated with increased levels of demethylated beta-cell-derived DNA in the bloodstream.
Conclusions:
- This study demonstrates that autoantigen-reactive human CD4(+) T cells can induce targeted destruction of pancreatic beta cells in a humanized mouse model.
- The developed model provides a valuable platform for investigating the mechanisms underlying human type 1 diabetes induction and progression.

